Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 11th:

ADMA Biologics, Inc. (ADMA Quick QuoteADMA - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

ADMA Biologics Inc Price and Consensus

ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote

ADMA’s shares gained 55.5% over the last three months compared with the S&P 500’s advance of 8.8%. The company possesses a Momentum Score  of A.

ADMA Biologics Inc Price

ADMA Biologics Inc price | ADMA Biologics Inc Quote

Arcutis Biotherapeutics, Inc. (ARQT Quick QuoteARQT - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Arcutis Biotherapeutics, Inc. Price and Consensus

Arcutis Biotherapeutics, Inc. price-consensus-chart | Arcutis Biotherapeutics, Inc. Quote

Arcutis’ shares gained 101% over the last month compared with the S&P 500’s advance of 2.5%. The company possesses a Momentum Score of A.

Arcutis Biotherapeutics, Inc. Price

Arcutis Biotherapeutics, Inc. price | Arcutis Biotherapeutics, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

(We are reissuing this article to correct a mistake. The original article, issued on January 11, 2024, should no longer be relied upon.)